CCO Oncology Podcast

189 Episodo

1. HER2-Positive Breast Cancer: Current Approaches for Quality Care

   Publicado: 28/7/2022
2. New Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022

   Publicado: 21/7/2022
3. New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022

   Publicado: 6/7/2022
4. Expert Insights on New Data From ASCO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

   Publicado: 30/6/2022
5. Expert Insight on Key Data From SGO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

   Publicado: 19/5/2022
6. Call to Action and Reflection: Inclusive, Compassionate, and High-Quality Healthcare for Transgender Individuals

   Publicado: 13/5/2022
7. Inclusive Healthcare for Transgender Individuals: Insights From a Healthcare Professional’s Transition Experience

   Publicado: 2/5/2022
8. Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials

   Publicado: 15/4/2022
9. Targeting TIGIT: Understanding New Approaches for Inhibiting the Immune Checkpoint Pathway

   Publicado: 7/4/2022
10. Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer

    Publicado: 6/4/2022
11. Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL

    Publicado: 31/3/2022
12. Expert Insights on Optimal Current Management of Patients With Cholangiocarcinoma

    Publicado: 21/3/2022
13. Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes

    Publicado: 14/3/2022
14. Expert Insights on Targeted Therapies for Advanced Systemic Mastocytosis

    Publicado: 10/3/2022
15. Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches

    Publicado: 25/2/2022
16. TKIs for Advanced HCC in the Second Line and Beyond

    Publicado: 22/2/2022
17. New Directions With PARP Inhibitors in Pancreatic Cancer

    Publicado: 21/2/2022
18. Evolving Therapy for Myeloma: Experts Discuss Patient Case Examples

    Publicado: 18/2/2022
19. Expert Insights on Advances in Immune Thrombocytopenia

    Publicado: 7/2/2022
20. Precision Medicine for aTTP: Expert Answers to Your Questions

    Publicado: 1/2/2022